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Abstract:  A patient with traumatic rotator cuff tear of the
left shoulder developed severe myofascial pain syndrome
with reflex sympathetic dystrophy (RSD) involving the
left upper extremity.  He was unable to tolerate any type of
manual therapy or needle treatment due to severe allodynia
in the whole left upper limb.  This patient presented for
treatment approximately 6 months after the onset of trauma.
Treatment consisting of specific myofascial trigger point
(MTrP) therapy, beginning with desensitization and gentle
massage on the MTrP of the first dorsal interosseous
muscle, followed by treatment of  MTrPs of the wrist-
finger extensors and anterior deltoid muscles was
commenced.  Allodynia was remarkably reduced and
further physical therapy with modalities was administered.
After 2 weeks of daily MTrP therapy, he received local
steroid injection to the left shoulder and continued MTrP
therapy 2-3 times per week.  Approximately 2 months
after the injection the patient was almost pain free with
nearly full range of motion in his left shoulder.  The
mechanism of MTrPs and their association with RSD is
discussed in this paper.
Keywords:  Manual therapy, muscle pain, Myofascial
Trigger Points, Reflex Sympathetic Dystrophy.
INTRODUCTION
Myofascial trigger point (MTrP) has been defined as a
highly localized painful or sensitive spot in a palpable taut
band of skeletal muscle fibers and is characteristically
found in myofascial pain syndrome (MPS)(1-15).  An
active MTrP is one with spontaneous pain or pain in
response to movement, while a latent MTrP is a sensitive
spot with pain or discomfort in response to compression
only (9, 10, 16).  MPS is usually caused by or associated
with acute injury or chronic repetitive trauma to soft
tissues , lesions involving various structures, or emotional
stress.  Many medical conditions (perpetuating factors),
including mechanical stress, metabolic or endocrine
inadequacies, chronic infections, or psychological factors,
may perpetuate MPS or may aggravate its severity (4, 14,
17).
The characteristics of a MTrP (4-6, 8-10, 13-16) include:
1). Specific tender spot (MTrP) in a palpable taut band
(also referred to as nodule).
2). Consistent and characteristic referred pain pattern
upon compression of an MTrP.
3). Local twitch response elicited by snapping palpation
on MTrPs in some muscles, or by needling of MTrPs
in almost all cases.
4). Restricted range of stretch due to shortening of muscle
fibres in a taut band.
5). Muscle weakness with no remarkable atrophy due to
waxing and waning phenomena of MTrPs.
6). Spread of pain to other parts of body in severe cases
of myofascial pain syndrome.
7). Associated referred autonomic phenomena including
vasomotor and pilomotor responses, and
hypersecretion.
In a study by Gerwin et al, it was found that “spot
tenderness”, “pain recognition”, and “taut band” are the
most reliable signs and the minimal criteria needed to
identify an MTrP, while “referred pain” and “local twitch
response” are most useful as confirmatory signs of the
MTrP (18, 19).  It has been concluded that it is essential
to have hands-on training in order to achieve a reliable
examination of MTrP (18, 19).  Speculation regarding
objective confirmatory findings have included
confirmatory electromyographic (EMG) recording and
ultrasound imaging of Latent Trigger Points (LTPs), the
spontaneous electrical activity of multiple active loci, and
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histological findings of contraction knots in the MTrP site
(20).
Treatment techniques for MTrP (3-6, 8-10, 12-15, 17, 21-
24) may include one or more of the following:
1). Manual therapy such as intermittent cold (with Fluori-
methane or Ethyl Chloride spray, or ice massage) and
stretch, which may be combined with other techniques
such as post-isometric relaxation (25, 26), deep
pressure soft tissue massage (by manual compression
on a MTrP, combined with gentle stretch of muscle
fibers in a MTrP region by moving the finger following
the direction of muscle fibres), mobilisation, or
manipulation.
2). Thermotherapy (usually combined with other therapy).
3). Electrotherapy by stimulation of muscle fibres around
an MTrP may facilitate relaxation of a taut band and
may improve local circulation.
4). Trigger point injections with local anaesthetic solution
or dry needling into an MTrP (27-33).
In addition to the above items, the following 3 issues are
essential for long-term inactivation of the MTrP:
1). Treatment of underlying causes.
2). Elimination of perpetuating factors.
3). Instruction in and consistent performance of a home
program including self-stretching techniques,
maintaining proper postures and therapeutic exercises,
and other physical medicine modalities.
The clinical observation of autonomic phenomena
associated with active MTrPs has been documented (12).
MTrPs have been found to be a complication (or a
manifestation) of reflex sympathetic dystrophy (RSD)
(34).  Trigger point injection could be an effective way to
treat muscle pain in some RSD patients (35).  In this case
report, a patient with severe MTrPs and RSD was
successfully treated with manual therapy for MTrP control.
CASE REPORT
History
A 25 year-old man was involved in an automobile accident
and developed pain and mild swelling in the left shoulder.
He was unable to move his left shoulder due to severe
shoulder pain (especially at the anterior shoulder).  Initial
x-ray examination of the left shoulder was unremarkable.
He was treated with non-steroid anti-inflammatory
medicine and physical therapy (including cold, heat, and
mobilisation).  He had improved gradually.
Approximately 3 weeks after the initial injury, he twisted
his left shoulder again when he was lifting a heavy object.
At that time, the pain was much worse than the intitial
presentation.  An MRI examination of the left shoulder
revealed evidence of rotator cuff tear at the supraspinatus
tendon portion.  No surgical intervention was recommended
at that time.  He continued to receive physical therapy.
However, the pain in the left shoulder was getting worse
gradually, especially during mobilisation therapy.  About
1 month later, the pain spread to the left arm, forearm,
wrist, and hand, progressively from the proximal to the
distal portions.  Swelling in the left hand was also noticed.
Gradually, he also experienced episodic cold sensation
with skin discoloration (pale or cyanosis) in his left hand.
He became hypersensitive to touch in the whole left upper
extremity and was unable to move his left upper limb due
to severe pain.  He was given oral steroid with little help.
He was unable to take any local injection therapy due to
severe pain and allodynia.  He had tried acupuncture
therapy but he was unable to tolerate the needle insertion.
The primary physician diagnosed reflex sympathetic
dystrophy and referred this patient for further management.
Physical Examination
The patient was first examined by the author approximately
6 months after the initial injury.  On examination, this
young man fixed his left upper limb in a position tightly
closed to his body with half flexion of his elbow and wrist.
Mild swelling and trophic change in the hand was noticed.
He was unable to move the whole left upper extremity in
all joints except slight flexion in the fingers.  Allodynia
was remarkable in the left shoulder-scapular area and the
whole upper extremity.  The skin in the left hand was very
cold.
Treatment – (Specific Myofascial Trigger Point
Therapy)
Since he refused to have any needle intervention (including
MTrP injection), he was first treated with gentle massage
on the MTrP of the left first dorsal interosseous muscle.
This procedure was first approached with gradual
desensitisation over the skin at the dorsum of the left hand.
About 5 minutes later, he was able to tolerate gentle
pressure to the MTrP of the left first dorsal interosseous
muscle.  Gentle massage over that MTrP was performed
for about 20 minutes with gradual increase of pressure to
the MTrP.  Then he was able to tolerate touch (with
reduced allodynia) on the left forearm and elbow.  Gentle
massage then was performed on the MTrP of the extensor
carpi radialis muscle and the lateral epicondyle area (the
common wrist-finger extensor tendons).  The pressure to
the MTrP was also increased gradually until he was able
to tolerate the pressure up to 4-5 Kg/cm
2
 approximately.
About 20 minutes later, allodynia in the left arm and
shoulder was also reduced. A similar massage procedure
was then performed over the MTrP of the left anterior
deltoid muscle for another 20 minutes, since this patient
had mentioned that the original pain site was in the anterior
shoulder.
Immediately after this treatment, he was able to move his
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left shoulder, elbow and wrist to more than half range with
no pain.  The swelling of the hand was reduced remarkably
and the hand was also getting warmer than before and he
was then able to tolerate further treatment with
thermotherapy (including hydrocollator heat packs and
ultrasound), electrotherapy (muscle stimulation), and
mobilisation.
Progress Examination
Examination of this patient, following specific myofascial
trigger point therapy, revealed diffuse active MTrPs in the
left shoulder girdle muscles and the whole left upper
extremity.  The most active MTrPs included upper
trapezius, supraspinatus, anterior deltoid, triceps, extensor
carpi radialis, extensor digitorum communis, and extensor
carpi ulnaris.  The range of motion of the left shoulder was
restricted in all directions especially in flexion, abduction
and external rotation.  He had severe pain the left shoulder
during active contraction of the shoulder abductors and
external rotators.  The muscle strength was remarkably
reduced in these 2 muscle groups due to shoulder pain.
There was hyperesthesia with mild allodynia in the anterior-
lateral shoulder, lateral forearm, and the radial aspect of
wrist and hand.  Deep tendon reflexes were within normal
limits.  The diagnosis was myofascial pain syndrome with
reflex sympathetic dystrophy involving the left upper
extremity due to left rotator cuff tear.
Outcome
The patient continued to have this specific MTrP therapy
once per day, except for a 2 week period where he was
unable to attend, and during that time received a local
injection to his left shoulder with Decadrone LA 8 mg plus
1% xylocaine 5 cc.  He had some increase in symptoms
each time before the subsequent MTrP therapy, since the
therapeutic effects only lasted for several hours after each
treatment.  He was also encouraged to move his left upper
limb as much as possible to suppliment the treatment
program.  He continued to receive MTrP therapy 2-3 times
per week after injection.  Two months after injection the
patient complained of almost no pain and had regained
nearly full range of motion in his left shoulder.  A follow-
up evaluation 6 months later revealed no evidence of
recurrence.
DISCUSSION
The appropriate treatment of traumatic tendon-ligament
injury includes physical therapy and anti-inflammatory
therapy (either systemic or local).  However, this patient
did not respond to the systemic anti-inflammatory therapy
and local physical therapy, and was not able to tolerate
local injection.  This case report demonstrated that specific
MTrP therapy (especially manual therapy) could help for
pain control so that the patient could tolerate a local steroid
injection.
MTrP phenomena are the common results and primary
pain problems of many different soft tissue lesions.  The
pathogenesis of MTrPs is probably related to integrative
mechanisms in the spinal cord in response to sensitised
nerve fibres associated with abnormal endplates (36, 37).
The evidence of spinal cord mechanism in the
pathogenesis of referred pain (38-42) and local twitch
responses (43-45) have been well documented.  As such
RSD could be secondary to severe MTrP problems.
When a MTrP is very active (or very severe), satellite
MTrPs may developed following the distribution of the
referred pain via spinal cord mechanism (37, 46-48).
Travell and Simons have illustrated the referred pain
pattern for each individual muscle in the Trigger Point
manual (12, 14, 15).  Referred pain has been well recognized
clinically, and its neurological mechanism has been
documented (38-41, 49-51).  There are silent (ineffective)
synaptic connections in the dorsal horn (3, 40, 41, 50, 51).
A sensitised or hyperirritable receptive field of a sensory
neuron may cause increased sensitivity and enlargement
of preexisting but “sleeping” nociceptive receptive fields
in other sites of the muscle or even in other muscles
corresponding to other sensory neurons by “unmasking”
the silent synaptic connections (38-41).  The afferent pain
fibres from muscle nociceptors in the original receptive
field have silent synaptic connections in the spinal cord to
the sensory neurons of other receptive fields.  When the
original receptive filed is sensitised, substance P and
calcitonin gene-related peptide may be released in the site
of dorsal horn neurons of the original receptive field and
may diffuse into the neurons of the other receptive fields
to activate the ineffective synaptic connection to become
an effective connection (41).  This would explain the
referred pain developed in the other receptive fields when
the original receptive field is stimulated.  For a severe
active MTrP, the irritation in its receptive field is very
strong and the threshold of other spinal neurons
corresponding to other receptive fields may be reduced
remarkably.  Finally spontaneous pain may occur in the
sites of receptive fields of other sensory neurons. The
expansion of receptive fields is caused by this “central
sensitisation” mechanism (52).  Through this mechanism,
new MTrPs, or “satellite MTrPs”, may develop in the
referred zone of the original MTrP.
The concept of a key trigger point (29, 30, 46, 53) or a
primary trigger point (14, 15) has been described in the
literature.  The key MTrP is the original MTrP produced
immediately after an injury.  However, if the original
pathological lesion is not appropriately treated, MTrPs
may spread out to the other sites of the body.  It is also
likely that these connections among the dorsal neurons
may also influence the autonomic systems in the spinal
cord so that RSD may develop in a severe case of MTrPs.
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Treatment of a key MTrP may suppress satellite MTrPs
(29, 30).  When the threshold of sensory neurons is
increased by treatment to the original MTrP, the threshold
of other sensory neurons corresponding to the satellite
MTrPs can also be increased.  Similarly, effective treatment
of a satellite MTrP in the referred zone of the key MTrP
may also increase the pain threshold of other satellite
MTrPs, or even the key MTrP, through the same spinal
cord mechanism, since all these satellite MTrPs have
certain connections with the key MTrP.
The pathogenesis and the therapeutic responses of severe
MTrPs in our patient can be explained with the above
mechanism.  An original trauma to the left rotator cuff in
this patient might activate latent MTrPs to become active
MTrPs (37, 46) in the shoulder girdle muscles to cause the
initial shoulder pain.  When the original traumatic lesion
was re-injured before it was completely healed, or a new
rotator cuff lesion developed from a re-injury, MTrPs in
the shoulder might be exacerbated, and might spread out
gradually.  Inappropriate or excessive stretching during
mobilization therapy might also cause persistent (unhealed)
lesion in the rotator cuff.  Gradually, shoulder MTrPs (key
MTrPs) might spread out to the whole limb.  The referred
zone of the key MTrP of anterior deltoid muscle covers the
areas of biceps and triceps muscles.  According to this
specific referred pain patterns, the satellite MTrPs induced
by the original anterior deltoid MTrP might have developed
in the biceps or triceps muscles.  Subsequently, MTrPs in
the triceps might cause satellite MTrPs in the extensor
carpi radialis muscles or other wrist-finger extensors
(under the referred zone of triceps MTrP).  Eventually,
satellite MTrPs in the first dorsal interosseous muscle
might develop since this muscle was under the referred
zone of MTrPs of extensor indicis muscle.  It was not
unlikely that MTrPs in the whole upper limb might develop
following the same mechanism.  Finally, it might affect the
autonomic system to develop RSD.
The MTrPs of the most distal muscle are usually the last
to develop if the original key MTrPs were in the proximal
portion of the limb, and thus might be the least sensitive (or
least irritable) ones.  This was the reason why the MTrP of
the first dorsal interosseous muscle was selected for initial
MTrP therapy.  Inactivation of the distal satellite MTrPs
might reduce the activity of other satellite MTrPs.
Similarly, the proximal MTrPs would be inactivated
gradually following subsequent MTrP therapy on other
relatively more distal MTrPs.
Before the original aetiological lesion (traumatic rotator
cuff inflammation) was completely eliminated, the
therapeutic effects of MTrP therapy might be only
temporary.  After local steroid injection to the left shoulder,
the inflammation of the injured rotator cuff might be
healing gradually, and thus all MTrPs became less and
less active, and finally completely subside.
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